Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Michael Bilerman maintains a Neutral rating on Healthpeak Properties and raises the price target from $20 to $22.
August 22, 2024 | 3:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup analyst Michael Bilerman maintains a Neutral rating on Healthpeak Properties and raises the price target from $20 to $22.
The increase in the price target from $20 to $22 suggests a positive outlook for Healthpeak Properties, which could lead to a slight upward movement in the stock price. However, the Neutral rating indicates that the analyst does not expect significant outperformance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100